Literature DB >> 9441811

Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation.

A Mizoe1, S Kondo, T Azuma, H Fujioka, K Tanaka, M Hashida, T Kanematsu.   

Abstract

BACKGROUND: Superoxide dismutase (SOD) derivatives modified with monosaccharides such as mannosylated SOD (Man-SOD) and galactosylated SOD (Gal-SOD) are taken up by parenchymal and nonparenchymal cells of the liver, respectively, via receptor-mediated endocytosis. We examined the preventive effects of Man- or Gal-SOD on cold ischemia-reperfusion injury in orthotopic liver transplantation (OLT) in rats.
METHODS: Male Lewis rats underwent OLT. Native SOD and modified SOD with mannose (Man-SOD) or galactose (Gal-SOD) were intravenously given just prior to reperfusion of the grafted liver.
RESULTS: After OLT, no significant changes in serum levels of aspartate aminotransferase or lactate dehydrogenase were evident among rats, with or without various types of SOD. However, tissue levels of Na+,K+-ATPase, an indicator of tissue viability, were significantly higher in rats treated with Man- and Gal-SODs compared with that in untreated OLT rats. When comparisons were made between Gal-SOD and Man-SOD, higher levels of Na+,K+-ATPase were evident in rats treated with Gal-SOD. Elevations of tissue levels of lipid peroxides were significantly inhibited by modified SODs. The survival rates of rats following OLT after prolonged cold preservation correlated with results of graft viability.
CONCLUSIONS: SOD derivatives, particularly Gal-SOD, have protective effects on cold ischemia-reperfusion injury during OLT in rats. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441811     DOI: 10.1006/jsre.1997.5215

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Effect of ischemia-reperfusion on Na+, K+-ATPase expression in human liver tissue allograft: image analysis by confocal laser scanning microscopy.

Authors:  Liliane Benkoel; Frank Dodero; Jean Hardwigsen; Eric Mas; Anne-Marie Benoliel; Danielle Botta-Fridlund; Yves Patrice Le Treut; Albert Chamlian; Dominique Lombardo
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 2.  Molecular mediators of liver ischemia and reperfusion injury: a brief review.

Authors:  Andrew J Vardanian; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

3.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

Review 4.  Factors in the pathophysiology of the liver ischemia-reperfusion injury.

Authors:  Eduardo E Montalvo-Jave; Tomas Escalante-Tattersfield; Jose A Ortega-Salgado; Enrique Piña; David A Geller
Journal:  J Surg Res       Date:  2007-07-27       Impact factor: 2.192

5.  Possible protection of sinusoidal endothelial cells by endothelin B receptor during hepatic warm ischemia-reperfusion.

Authors:  Kyoko Mochizuki; Yasuharu Ohno; Takashi Kanematsu; Yasuko Sakurai-Yamashita; Masami Niwa; Yoshitaka Hishikawa; Takehiko Koji
Journal:  Surg Today       Date:  2007-05-28       Impact factor: 2.549

6.  Protection of rat liver against hepatic ischemia-reperfusion injury by a novel selenocysteine-containing 7-mer peptide.

Authors:  Qianqian Jiang; Yu Pan; Yupeng Cheng; Huiling Li; Hui Li
Journal:  Mol Med Rep       Date:  2016-07-01       Impact factor: 2.952

7.  Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat.

Authors:  Ismail Ben Mosbah; Yann Mouchel; Julie Pajaud; Catherine Ribault; Catherine Lucas; Alexis Laurent; Karim Boudjema; Fabrice Morel; Anne Corlu; Philippe Compagnon
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.